Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Fusion
ORGANISM(S): Trypanosoma Brucei
TISSUE(S): Cell Culture
DISEASE(S): Trypanosomiasis
SUBMITTER: Amrita Sharma
LAB HEAD: Amrita Sharma
PROVIDER: PXD036393 | Pride | 2023-03-11
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
AS120419_013120_A.mzML | Mzml | |||
AS120419_013120_A.mzXML | Mzxml | |||
AS120419_013120_A.mzid.gz | Mzid | |||
AS120419_013120_A.raw | Raw | |||
AS120419_013120_A.xlsx | Xlsx |
Items per page: 5 1 - 5 of 60 |
Sharma Amrita A Cipriano Michael M Ferrins Lori L Hajduk Stephen L SL Mensa-Wilmot Kojo K
iScience 20221007 11
NEU-4438 is a lead for the development of drugs against <i>Trypanosoma brucei</i>, which causes human African trypanosomiasis. Optimized with phenotypic screening, targets of NEU-4438 are unknown. Herein, we present a cell perturbome workflow that compares NEU-4438's molecular modes of action to those of SCYX-7158 (acoziborole). Following a 6 h perturbation of trypanosomes, NEU-4438 and acoziborole reduced steady-state amounts of 68 and 92 unique proteins, respectively. After analysis of proteom ...[more]